Beclomethasone Dipropionate (80 and 160 mcg/Day) delivered via Breath-Actuated Inhaler

beclomethasone dipropionate · Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beclomethasone Dipropionate (80 and 160 mcg/Day) delivered via Breath-Actuated Inhaler, covering 2017-12-11 to 2017-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma [Phase 3]

See pricing